TY - JOUR
T1 - Protein transduction therapy into cochleae via the round window niche in guinea pigs
AU - Takeda, Hiroki
AU - Kurioka, Takaomi
AU - Kaitsuka, Taku
AU - Tomizawa, Kazuhito
AU - Matsunobu, Takeshi
AU - Hakim, Farzana
AU - Mizutari, Kunio
AU - Miwa, Toru
AU - Yamada, Takao
AU - Ise, Momoko
AU - Shiotani, Akihiro
AU - Yumoto, Eiji
AU - Minoda, Ryosei
N1 - Publisher Copyright:
© 2016 Official journal of the American Society of Gene & Cell Therapy
PY - 2016/3/16
Y1 - 2016/3/16
N2 - Cell-penetrating peptides (CPPs) are short sequences of amino acids that facilitate the penetration of conjugated cargoes across mammalian cell membranes, and as such, they may provide a safe and effective method for drug delivery to the inner ear. Simple polyarginine peptides have been shown to induce significantly higher cell penetration rates among CPPs. Herein, we show that a peptide consisting of nine arginines (“9R”) effectively delivered enhanced green fluorescent protein (EGFP) into guinea pig cochleae via the round window niche without causing any deterioration in auditory function. A second application, 24 hours after the first, prolonged the presence of EGFP. To assess the feasibility of protein transduction using 9R-CPPs via the round window, we used “X-linked inhibitor of apoptosis protein” (XIAP) bonded to a 9R peptide (XIAP-9R). XIAP-9R treatment prior to acoustic trauma significantly reduced putative hearing loss and the number of apoptotic hair cells loss in the cochleae. Thus, the topical application of molecules fused to 9R-CPPs may be a simple and promising strategy for treating inner ear diseases.
AB - Cell-penetrating peptides (CPPs) are short sequences of amino acids that facilitate the penetration of conjugated cargoes across mammalian cell membranes, and as such, they may provide a safe and effective method for drug delivery to the inner ear. Simple polyarginine peptides have been shown to induce significantly higher cell penetration rates among CPPs. Herein, we show that a peptide consisting of nine arginines (“9R”) effectively delivered enhanced green fluorescent protein (EGFP) into guinea pig cochleae via the round window niche without causing any deterioration in auditory function. A second application, 24 hours after the first, prolonged the presence of EGFP. To assess the feasibility of protein transduction using 9R-CPPs via the round window, we used “X-linked inhibitor of apoptosis protein” (XIAP) bonded to a 9R peptide (XIAP-9R). XIAP-9R treatment prior to acoustic trauma significantly reduced putative hearing loss and the number of apoptotic hair cells loss in the cochleae. Thus, the topical application of molecules fused to 9R-CPPs may be a simple and promising strategy for treating inner ear diseases.
UR - http://www.scopus.com/inward/record.url?scp=85015145921&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85015145921&partnerID=8YFLogxK
U2 - 10.1038/mtm.2016.55
DO - 10.1038/mtm.2016.55
M3 - Article
AN - SCOPUS:85015145921
SN - 2329-0501
VL - 3
SP - 16055
JO - Molecular Therapy - Methods and Clinical Development
JF - Molecular Therapy - Methods and Clinical Development
ER -